Utility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia.

about

Utility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia.

Item

http://www.wikidata.org/entity/Q37029566

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Utility of in-house fluconazol ...... n the treatment of candidemia.

@en

Utility of in-house fluconazol ...... n the treatment of candidemia.

@nl

type

Item

label

Utility of in-house fluconazol ...... n the treatment of candidemia.

@en

Utility of in-house fluconazol ...... n the treatment of candidemia.

@nl

prefLabel

Utility of in-house fluconazol ...... n the treatment of candidemia.

@en

Utility of in-house fluconazol ...... n the treatment of candidemia.

@nl

P1476

Utility of in-house fluconazol ...... n the treatment of candidemia.

@en

P2093

David W Kubiak

http://www.w3.org/2001/XMLSchema#string

Dimitrios Farmakiotis

http://www.w3.org/2001/XMLSchema#string

Linda M Weiser

http://www.w3.org/2001/XMLSchema#string

Lindsey R Baden

http://www.w3.org/2001/XMLSchema#string

Randy M Hollins

http://www.w3.org/2001/XMLSchema#string

Sara E Rostas

http://www.w3.org/2001/XMLSchema#string

Viktoria Arons

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of invasive candidiasis: a persistent public health problem

Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.

Drug-resistant Candida glabrata infection in cancer patients.

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata.

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations

The case for antifungal stewardship.

Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.

Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation.

P304

223-226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DIAGMICROBIO.2015.11.018

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francisco M. Marty

Sophia Koo

Lindsey R Baden

P577

2015-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284786668

http://www.w3.org/2001/XMLSchema#string

P698

26763713

http://www.w3.org/2001/XMLSchema#string

P932

4917365

http://www.w3.org/2001/XMLSchema#string